Prostat
Prostat, licence 80037689: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Herbase Nutrition Ltd.
- NPN or DIN-HM
- 80037689
- Status
- Active licence
- Licence date
- 22 November 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Plantago asiatica Source : Graine(s) Extraction ratio : 20:1 Dry plant equivalent : 520 mg | 40.0 mg | Not calculated |
| Succinum Source : Minérale | 146.0 mg | Not calculated |
| Cinnamomum aromaticum Source : Branche(s) Extraction ratio : 5:1 Dry plant equivalent : 13.2 mg | 0.00176 mL | Not calculated |
| Cinnamomum aromaticum Source : Feuille Extraction ratio : 5:1 Dry plant equivalent : 13.2 mg | 0.00176 mL | Not calculated |
| Anemone raddeana Source : Rhizome Extraction ratio : 20:1 Dry plant equivalent : 650 mg | 50.0 mg | Not calculated |
| Lycopus lucidus Source : Plante(s) entière Extraction ratio : 20:1 Dry plant equivalent : 650 mg | 50.0 mg | Not calculated |
| Phellodendron chinense Source : Écorce (tige) Extraction ratio : 20:1 Dry plant equivalent : 650 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditionally used in Chinese Medicine to clear and disinhibit damp turbidity, resolve stasis for disorders such as mild and moderate dribbling urinary block by heat and stasis in the lower energizer manifested s urinary stoppage, narrow stream, frequent and urgent urination, prostatitis and prostate hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80037689
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.